Cerus
CERS
$1.71
Share price
0.59%
Change (1 day)
-25.33%
Change (1 year)
Categories
Cerus (CERS) - Cash on Hand
Cash on Hand as of December 2023 : $65.85 M
According to Cerus's latest financial reports the company has $65.85 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Cerus - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $65.85 M | -35.54% |
| 2022-12-31 | $0.10 B | -21.03% |
| 2021-12-31 | $0.12 B | -3.17% |
| 2020-12-31 | $0.13 B | 55.85% |
| 2019-12-31 | $85.71 M | -27.1% |
| 2018-12-31 | $0.11 B | 93.71% |
| 2017-12-31 | $60.69 M | -15.26% |
| 2016-12-31 | $71.62 M | -33.6% |
| 2015-12-31 | $0.10 B | 110.32% |
| 2014-12-31 | $51.29 M | -11.07% |
| 2013-12-31 | $57.67 M | 116.05% |
| 2012-12-31 | $26.69 M | 3.54% |
| 2011-12-31 | $25.78 M | -14.08% |
| 2010-12-31 | $30 M | 50.56% |
| 2009-12-31 | $19.93 M | -11.72% |
| 2008-12-31 | $22.57 M | -60.28% |
| 2007-12-31 | $56.85 M | -39.14% |
| 2006-12-31 | $93.41 M | 103.94% |
| 2005-12-31 | $45.8 M | -51.95% |
| 2004-12-31 | $95.33 M | -13.34% |
| 2003-12-31 | $0.11 B | 71.04% |
| 2002-12-31 | $64.31 M | -47.9% |
| 2001-12-31 | $0.12 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Boston Scientific BSX | $0.86 B | 1,213.55% | 🇺🇸 USA |
 Utah Medical Products UTMD | $88.2 M | 33.95% | 🇺🇸 USA |
 Haemonetics HAE | $0.19 B | 194.57% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $7.57 M | -88.50% | 🇺🇸 USA |